Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Joan Bolling"'
Autor:
Joan Bolling, Roy T. Sabo, Matthew Risendal, Amir A. Toor, William B. Clark, John M. McCarty, Priscilla Mpasi, Catherine H. Roberts, Harold M. Chung, Allison F. Hazlett
Publikováno v:
Blood. 120:3123-3123
Abstract 3123 Background: Multiple myeloma (MM) is a plasma cell malignancy with variable prognosis depending on disease features such as β2m level and cytogenetics. High dose therapy and stem cell transplantation (SCT) remains the current standard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ffa01c2a2fa3eb5506ea4469716cebf
https://doi.org/10.1182/blood.v120.21.3123.3123
https://doi.org/10.1182/blood.v120.21.3123.3123
Feasibility of risk stratified allocation to single versus tandem autologous SCT in multiple myeloma
Autor:
John M. McCarty, Allison Hazlett, Roy T. Sabo, Matthew Risendal, Catherine H. Roberts, Priscilla Mpasi, Harold M. Chung, William B. Clark, Amir A. Toor, Joan Bolling
Publikováno v:
Journal of Clinical Oncology. 30:e18550-e18550
e18550 Background: Multiple myeloma (MM) is a plasma cell malignancy with variable prognosis depending on disease features such as β2m and cytogenetics. High dose therapy and stem cell transplantation (SCT) remains the current standard of care for M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4ffc11bb7bf185d488320e8f44f4c35
https://doi.org/10.1200/jco.2012.30.15_suppl.e18550
https://doi.org/10.1200/jco.2012.30.15_suppl.e18550